[Skip to Navigation]
Views 664
Citations 0
Invited Commentary
April 2, 2020

BEST1—One Gene, Many Diseases

Author Affiliations
  • 1Inherited Retinal Disorders Service, Massachusetts Eye and Ear Infirmary, Harvard Department of Ophthalmology, Boston
  • 2Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Department of Ophthalmology, Boston
JAMA Ophthalmol. 2020;138(5):552. doi:10.1001/jamaophthalmol.2020.0683

Retinal dystrophies associated with the gene BEST1, collectively known as bestrophinopathies, are phenotypically heterogeneous. Although Best vitelliform macular dystrophy (BVMD) is the most common bestrophinopathy, the distinct clinical conditions encompassed by the bestrophinopathies vary in features, including the mode of inheritance and degree of macular vs peripheral retinal involvement. In this issue of JAMA Ophthalmology, Shah et al1 assess the diversity of bestrophinopathies identified in the patient population of a single academic center. In an evaluation of 36 patients from 25 families for whom genetic testing results revealed disease-causing BEST1 sequence variants, the authors identify 3 of the distinct clinical phenotypes previously associated with this gene: BVMD, autosomal recessive bestrophinopathy (ARB), and adult-onset vitelliform macular dystrophy. Their cohort does not include individuals with autosomal dominant vitreoretinochoroidopathy or retinitis pigmentosa (RP). Indeed, the authors revisited a previously published family with a diagnosis of BEST1-associated autosomal recessive RP2 and revised the clinical diagnosis to ARB. The identification of 2 patients with BEST1-associated adult-onset vitelliform macular dystrophy in this cohort is a reminder of the multiple pathways, both genetic and presumably multifactorial, that can culminate in this clinical phenotype.3

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words